Spanish National Cancer Research Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Spanish National Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9416
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomputing program, human cancer genetics program, experimental therapeutics program, biotechnology program and clinical research programs. CNIO carries out clinical trials for various tumor types such as colon cancer, pancreas, lung, breast, kidney, prostate, hematological neoplasms, brain, sarcomas, and others. The center also provides several training programs and courses for medical residents and master degree holders in other biomedical areas. It offers practical laboratory courses for undergraduate students and future technicians. CNIO is headquartered in Madrid, Spain.

Spanish National Cancer Research Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10
Licensing Agreements 11
Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11
Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12
Spanish National Cancer Research Center – Key Competitors 13
Spanish National Cancer Research Center – Key Employees 14
Spanish National Cancer Research Center – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Aug 20, 2018: CNIO researchers prove that gene therapy vectors carrying the telomerase gene do not increase the risk of cancer in cancer-prone mouse models 16
Jun 11, 2018: A new therapy proves effective against brain metastasis 18
Jun 04, 2018: Deciphering the role of cohesin in genome 3D structure helps understanding tumour cells 20
Apr 17, 2018: A potential setback in the personalised medicine of cancer 21
Apr 13, 2018: A novel precision cancer model opens doors to personalised cancer treatment 23
Feb 14, 2018: A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue 24
Feb 01, 2018: CNIO researchers discover a potential new therapeutic strategy for pancreatic cancer 25
Product News 27
Apr 13, 2018: Generated mouse model offers possibility of personalised cancer treatment 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Key Facts 2
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Spanish National Cancer Research Center, Deals By Therapy Area, 2012 to YTD 2018 8
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 10
Merck Enters Into Licensing Agreement With Spanish National Cancer Research Centre 11
Inflection Biosciences Enters Into Licensing Agreement With Spanish National Cancer Research Centre For Kinase Inhibitors 12
Spanish National Cancer Research Center, Key Competitors 13
Spanish National Cancer Research Center, Key Employees 14

List of Figures
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Spanish National Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Spanish National Cancer Research Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zion Oil & Gas Inc (ZN):企業の財務・戦略的SWOT分析
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • Pembina Pipeline Corp (PPL):企業の財務・戦略的SWOT分析
    Pembina Pipeline Corp (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cembra Money Bank AG:企業の戦略・SWOT・財務情報
    Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report Summary Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Taylor Wessing Llp:企業の戦略・SWOT・財務分析
    Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Merafe Resources Ltd:企業の戦略・SWOT・財務分析
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • China Mobile Limited:戦略・SWOT・企業財務分析
    China Mobile Limited - Strategy, SWOT and Corporate Finance Report Summary China Mobile Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • curasan AG (CUR):企業の財務・戦略的SWOT分析
    curasan AG (CUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • WorleyParsons Ltd (WOR):企業の財務・戦略的SWOT分析
    WorleyParsons Ltd (WOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • TyraTech Inc (TYR):企業の財務・戦略的SWOT分析
    Summary TyraTech Inc (TyraTech) is a clean technology and life science company that manufactures, markets, and develops insect and parasite control products. The company offers products such as equine fly spray, head lice solutions, insect repellent, insect and parasite products, and production anim …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務情報
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Celator Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celator Pharmaceuticals Inc (Celator) is a clinical-stage biopharmaceutical company that develops and distributes therapies for treating cancer disease. The company’s products include cytarabine and daunorubicin liposomal formulation, irinotecan HCI and floxuridine and hydrophobic docetaxel …
  • CRH Medical Corp (CRH):企業の財務・戦略的SWOT分析
    Summary CRH Medical Corp (CRH Medical), is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medi …
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Al Salam Bank BSC (SALAM):企業の財務・戦略的SWOT分析
    Al Salam Bank BSC (SALAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Qiagen NV (QIA)-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. Its solutions include sample and assay technologies, bioinformatics and automation systems. Qiagen’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue. The company’s produc …
  • Acumen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Acumen Pharmaceuticals Inc (Acumen) is a pharmaceutical company that discovers and develops therapeutics and diagnostics services for the treatment of Alzheimer’s disease and other related neurodegenerative conditions. It focuses on development of ADDL (amyloid-beta derived diffusible ligand …
  • Indiana Municipal Power Agency-エネルギー分野:企業M&A・提携分析
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆